The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Spinal Cord Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Spinal Cord Diseases


Psychiatry related information on Spinal Cord Diseases


High impact information on Spinal Cord Diseases


Chemical compound and disease context of Spinal Cord Diseases


Biological context of Spinal Cord Diseases


Anatomical context of Spinal Cord Diseases


Gene context of Spinal Cord Diseases


Analytical, diagnostic and therapeutic context of Spinal Cord Diseases


  1. Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter. Goudreau, G., Carpenter, S., Beaulieu, N., Jolicoeur, P. Nat. Med. (1996) [Pubmed]
  2. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Giraudon, P., Buart, S., Bernard, A., Thomasset, N., Belin, M.F. Prog. Neurobiol. (1996) [Pubmed]
  3. Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy. Lau, A., Nightingale, S., Taylor, G.P., Gant, T.W., Cann, A.J. Blood (1998) [Pubmed]
  4. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP. Nagai, M., Yamano, Y., Brennan, M.B., Mora, C.A., Jacobson, S. Ann. Neurol. (2001) [Pubmed]
  5. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N. Ann. Neurol. (1993) [Pubmed]
  6. Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Griffin, D.E., Wesselingh, S.L., McArthur, J.C. Ann. Neurol. (1994) [Pubmed]
  7. Folates: supplemental forms and therapeutic applications. Kelly, G.S. Alternative medicine review : a journal of clinical therapeutic. (1998) [Pubmed]
  8. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Keating, J.N., Trimble, K.C., Mulcahy, F., Scott, J.M., Weir, D.G. Lancet (1991) [Pubmed]
  9. Myelopathy after stopping zidovudine. Loke, R.H., Wade, J.P., Murray-Lyon, I.M. Lancet (1988) [Pubmed]
  10. Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Andrianakos, A.A., Duffy, J., Suzuki, M., Sharp, J.T. Ann. Intern. Med. (1975) [Pubmed]
  11. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Tendler, C.L., Greenberg, S.J., Blattner, W.A., Manns, A., Murphy, E., Fleisher, T., Hanchard, B., Morgan, O., Burton, J.D., Nelson, D.L. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  12. Cytarabine and neurologic toxicity. Baker, W.J., Royer, G.L., Weiss, R.B. J. Clin. Oncol. (1991) [Pubmed]
  13. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Konttinen, Y.T., Kinnunen, E., von Bonsdorff, M., Lillqvist, P., Immonen, I., Bergroth, V., Segerberg-Konttinen, M., Friman, C. Arthritis Rheum. (1987) [Pubmed]
  14. Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone. Levine, S., Sowinski, R. Am. J. Pathol. (1976) [Pubmed]
  15. Compressive cervical myelopathy due to calcium pyrophosphate dihydrate deposition disease: report of a case and review of the literature. Fye, K.H., Weinstein, P.R., Donald, F. Arch. Intern. Med. (1999) [Pubmed]
  16. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. Dorfman, D., DiRocco, A., Simpson, D., Tagliati, M., Tanners, L., Moise, J. AIDS (1997) [Pubmed]
  17. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1. Ikeda, R., Yoshida, K., Tsukahara, S., Sakamoto, Y., Tanaka, H., Furukawa, K., Inoue, I. J. Biol. Chem. (2005) [Pubmed]
  18. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Kodama, D., Saito, M., Matsumoto, W., Sabouri, A.H., Izumo, S., Arimura, K., Usuku, K., Bangham, C.R., Osame, M. J. Neuroimmunol. (2004) [Pubmed]
  19. Acute- and insidious-onset myelopathy of undetermined aetiology: contribution of paraclinical tests to the diagnosis of multiple sclerosis. Filippi, M., Martinelli, V., Locatelli, T., Medaglini, S., Poggi, A., Visciani, A., Scotti, G., Canal, N., Comi, G. J. Neurol. (1990) [Pubmed]
  20. Clinical course of patients with ossification of the posterior longitudinal ligament: a minimum 10-year cohort study. Matsunaga, S., Sakou, T., Taketomi, E., Komiya, S. J. Neurosurg. (2004) [Pubmed]
  21. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients. Arai, M., Kannagi, M., Matsuoka, M., Sato, T., Yamamoto, N., Fujii, M. AIDS Res. Hum. Retroviruses (1998) [Pubmed]
  22. The pathogenesis of superficial siderosis of the central nervous system. Koeppen, A.H., Dickson, A.C., Chu, R.C., Thach, R.E. Ann. Neurol. (1993) [Pubmed]
  23. Cervical myelopathy caused by ossification of the posterior longitudinal ligament in ankylosing spondylitis. Olivieri, I., Fiandra, E., Muscat, C., Barozzi, L., Tomassini, C., Gerli, R. Arthritis Rheum. (1996) [Pubmed]
  24. AIDS-associated vacuolar myelopathy. A morphometric study. Tan, S.V., Guiloff, R.J., Scaravilli, F. Brain (1995) [Pubmed]
  25. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Tyor, W.R., Glass, J.D., Baumrind, N., McArthur, J.C., Griffin, J.W., Becker, P.S., Griffin, D.E. Neurology (1993) [Pubmed]
  26. Refractory giant cell arteritis with spinal cord infarction. Galetta, S.L., Balcer, L.J., Lieberman, A.P., Syed, N.A., Lee, J.M., Oberholtzer, J.C. Neurology (1997) [Pubmed]
  27. Diagnosis and treatment of ossification of the posterior longitudinal ligament of the spine: report of eight cases and literature review. Trojan, D.A., Pouchot, J., Pokrupa, R., Ford, R.M., Adamsbaum, C., Hill, R.O., Esdaile, J.M. Am. J. Med. (1992) [Pubmed]
  28. Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I. McArthur, J.C., Griffin, J.W., Cornblath, D.R., Griffin, D.E., Tesoriero, T., Kuncl, R., Gibbs, C.J., Farzadegan, H., Johnson, R.T. Neurology (1990) [Pubmed]
  29. Increased intrathecal release of soluble fractalkine in HIV-infected patients. Sporer, B., Kastenbauer, S., Koedel, U., Arendt, G., Pfister, H.W. AIDS Res. Hum. Retroviruses (2003) [Pubmed]
  30. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Nishimura, M., Maeda, M., Matsuoka, M., Mine, H., Saji, H., Matsui, M., Kuroda, Y., Kawakami, H., Uchiyama, T. Hum. Immunol. (2000) [Pubmed]
  31. Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease. Nobuhara, Y., Usuku, K., Saito, M., Izumo, S., Arimura, K., Bangham, C.R., Osame, M. Immunogenetics (2006) [Pubmed]
  32. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Ward, M.M. Arthritis Rheum. (2004) [Pubmed]
  33. Remission of HIV-associated myelopathy after initiation of lopinavir in a patient with extensive previous exposure to highly active antiretroviral therapy. Eyer-Silva, W.A., Couto-Fernandez, J.C., Caetano, M.R., Chequer-Fernandez, S.L., Pinto, J.F., Morais-De-Sá, C.A., Morgado, M.G. AIDS (2002) [Pubmed]
  34. Upper cervical myelopathy associated with low CSF pressure: a complication of ventriculoperitoneal shunt. Miyazaki, T., Chiba, A., Nishina, H., Uesaka, Y., Nakase, H., Kanazawa, I. Neurology (1998) [Pubmed]
  35. Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum. Link, H., Cruz, M., Gessain, A., Gout, O., de Thé, G., Kam-Hansen, S. Neurology (1989) [Pubmed]
  36. Spinal cord size in syringomyelia: change with position on metrizamide myelography. Kan, S., Fox, A.J., Viñuela, F., Debrun, G. Radiology. (1983) [Pubmed]
WikiGenes - Universities